OPENLAB EVIDENCE

Evidence index.

Records, source chains, documents, analytes, and reported results.

Evidence legend

OPENLAB VERIFIEDUnavailable

Record index

OPENLAB VERIFIED

ENDURASHRED

Batch
OL2212
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: ENDURASHRED
  2. Batch: OL2212
  3. Documents: 3
  4. Reported results: 6

Documents

Analytes and results

LGD-4033

Purity
>99%
Concentration
8.68 mg
Compound identification
LGD-4033 identification reported

MK-2866

Purity
>99%
Concentration
7.94 mg
Compound identification
MK-2866 identification reported
View product
OPENLAB VERIFIED

EPISTANE

Batch
OL2210
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of an AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: EPISTANE
  2. Batch: OL2210
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

EPISTANE

Purity
>99.99%
Concentration
14.25 mg
Compound identification
EPISTANE identification reported
View product
OPENLAB VERIFIED

GW-501516

Batch
OL2203
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD, GC-MS.

Source chain

  1. Product: GW-501516
  2. Batch: OL2203
  3. Documents: 6
  4. Reported results: 3

Documents

Analytes and results

GW-501516

Purity
>99%
Concentration
11.77 mg in tested sample
Compound identification
GW-501516 identification reported
View product
OPENLAB VERIFIED

HALO

Batch
OL2209
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: HALO
  2. Batch: OL2209
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

Halo

Purity
>90%
Concentration
34.7 mg
Compound identification
Halo identification reported
View product
OPENLAB VERIFIED

LGD-4033

Batch
OL2204
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: LGD-4033
  2. Batch: OL2204
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

LGD-4033

Purity
>99.99%
Concentration
10.06 mg
Compound identification
LGD-4033 identification reported
View product
OPENLAB VERIFIED

M-STEN

Batch
OL2208
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of an AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: M-STEN
  2. Batch: OL2208
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

M-STEN

Purity
99%
Concentration
7.05 mg
Compound identification
M-STEN identification reported
View product
OPENLAB VERIFIED

MASS GH

Batch
OL2211
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: MASS GH
  2. Batch: OL2211
  3. Documents: 3
  4. Reported results: 6

Documents

Analytes and results

LGD-4033

Purity
>99.99%
Concentration
5.4 mg
Compound identification
LGD-4033 identification reported

MK-677

Purity
>99%
Concentration
9.66 mg
Compound identification
MK-677 identification reported
View product
OPENLAB VERIFIED

MENT

Batch
OL2206
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of an AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: MENT
  2. Batch: OL2206
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

Trestolone

Purity
99%
Concentration
23.62 mg
Compound identification
Trestolone identification reported
View product
OPENLAB VERIFIED

MK-2866

Batch
OL2201
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: MK-2866
  2. Batch: OL2201
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

MK-2866

Purity
>99%
Concentration
16.02 mg
Compound identification
MK-2866 identification reported
View product
OPENLAB VERIFIED

MK-677

Batch
OL2202
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: MK-677
  2. Batch: OL2202
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

MK-677

Purity
>99%
Concentration
14.3 mg
Compound identification
MK-677 identification reported
View product
OPENLAB VERIFIED

RAD-140

Batch
OL2205
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: RAD-140
  2. Batch: OL2205
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

RAD140

Purity
>99%
Concentration
7.8 mg
Compound identification
RAD140 identification reported
View product
OPENLAB VERIFIED

S-23

Batch
OL2289
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: S-23
  2. Batch: OL2289
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

S-23

Purity
99.89%
Concentration
11.31 mg
Compound identification
S-23 identification reported
View product
OPENLAB VERIFIED

S-4

Batch
OL2287
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: S-4
  2. Batch: OL2287
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

Andarine

Purity
99.41%
Concentration
27.5 mg
Compound identification
Andarine identification reported
View product
OPENLAB VERIFIED

TRENAVAR

Batch
OL2207
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: TRENAVAR
  2. Batch: OL2207
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

Trenavar

Purity
97.48%
Concentration
27.03 mg
Compound identification
Trenavar identification reported
View product
OPENLAB VERIFIED

YK-11

Batch
OL2288
Evidence state
OPENLAB VERIFIED
Methodology
Qualitative and quantitative analysis of non-AAS sample. Methods: HPLC-MS, HPLC-DAD.

Source chain

  1. Product: YK-11
  2. Batch: OL2288
  3. Documents: 3
  4. Reported results: 3

Documents

Analytes and results

YK-11

Purity
>99.99%
Concentration
10.23 mg
Compound identification
YK-11 identification reported
View product